Skip to main content
OpenTrials
Completed

NCT Number: NCT02200458

Near-infrared Software Performance Study

This study will look at the performance capabilities of software for VeinViewer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Christie Medical Holdings, Inc.

Memphis, Tennessee, 38104, United States

About this study

This study will look at the performance capabilities of future software for VeinViewer.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be 18 years of age or older
  • Must be considered to be in overall good health by investigator
  • Must pass all prescreening questions
  • Must be able to read and understand English

Exclusion criteria

  • Presence of tattoos, scarring, and/or extensive hair in the areas to be assessed for cannulation.
  • IV cannulation in the arms or hands in the previous 4 weeks.

Treatment and study plan

VeinViewer

Device

Updated software on the VeinViewer device will be used to project an image of the vasculature on the skin.

Primary outcomes

  1. Number of Participants for Whom Successful Visualization of Vasculature Was Achieved

    Time frame: One day

Sponsors and collaborators

Lead sponsor

Christie Medical Holdings, Inc.

Industry

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Jul 25, 2014
Registry last updated
Mar 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.